Trust Deficit Weighs on CSG: Record Orders and New Fuse JV Fail to Lift Stock from 52-Week Lows
05.06.2026 - 22:30:50 | boerse-global.de
The Czechoslovak Group (CSG) is delivering everything investors traditionally want to see: double-digit revenue growth, an expanding order book, and new strategic contracts. Yet the market continues to punish the stock. On Friday, shares closed at €15.10, down 3.58% on the day and 16.41% lower over the past seven trading days — a stark contrast to the company’s operational momentum.
The disconnect is glaring when set against first-quarter numbers. CSG lifted revenue by 13.8% year-on-year to €1.544 billion, while operating profit (EBIT) rose 8.7% to €372 million. The order backlog swelled from €15 billion to €17 billion, and the pipeline of ongoing negotiations reached €27 billion. None of that has arrested the share’s descent.
In a bid to deepen its vertical integration, CSG has signed two new supply agreements with undisclosed European NATO members for mechanical and electronic fuzes used in large-calibre ammunition. The contracts, with a combined value in the high double-digit millions of euros, mark the first significant order intake of Fuchs Electronics Europe — a joint venture created with South Africa’s Reunert. The joint venture, based in Slovakia, targets a long-standing bottleneck in European defence: fuze availability, which has constrained ammunition production for years.
Should investors sell immediately? Or is it worth buying CSG?
CSG’s own large-calibre ammunition output is ramping up sharply. The company now expects to produce around 850,000 rounds by the end of 2026, up from 550,000 last year. An additional 400,000 rounds will come from reactivated legacy production lines, bringing the total potential output to 1.25 million rounds. It is a tangible demonstration of capacity expansion that management believes will remain in demand regardless of diplomatic developments.
Despite the share price rout, CSG has reaffirmed its full-year 2026 guidance: revenue between €7.4 billion and €7.6 billion, an adjusted EBIT margin of 24–25%, capital expenditure of roughly 8.5% of sales, and net debt kept below 1.3 times EBITDA. The Land Systems and large-calibre ammunition segments remain the primary growth drivers.
Technically, the picture is bleak. The stock now trades 58% below its January 52-week high of €36.05 and 23% under its 50-day moving average of €19.66. The relative strength index sits at 32.2, flirting with oversold territory but not yet triggering a decisive reversal. A brief bounce in Prague on Thursday — where CSG shares added 1.01% to 381.8 koruna — failed to translate into lasting momentum on the Euro listing, and Friday’s session erased any hopes of a stabilisation.
Market participants appear trapped in a trust deficit that goes beyond CSG alone. Analysts note that every attempted recovery is being seized as a selling opportunity, not a buying signal. The defence sector broadly is suffering from a credibility gap, where strong fundamental data is being dismissed amid broader investor unease. CSG management has sought to counter this by emphasising that even a potential ceasefire in active conflicts would not materially dent demand, as NATO’s stockpile replenishment to modern standards will underpin order intake for years to come. Whether the market will eventually reassess that view may only become clear with the next quarterly report in autumn.
Ad
CSG Stock: New Analysis - 5 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
